Yahoo Web Search

Search results

1. • 

     AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer

     BioPharma Dive via Yahoo Finance· 6 days ago

     Median progression-free survival among those on Imfinzi was 17 months, about eight months longer...

2. • 

     Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumab

     MedPage Today· 5 days ago

     ...OS was 55.9 months in the durvalumab group compared with 33.4 months in the placebo group (HR...

3. • 

     With new Enhertu data, an ADC could overtake chemo in breast cancer

     BioPharma Dive via Yahoo Finance· 6 days ago

     Layman also didn’t take part in the trial, but is an investigator in a different Enhertu study....

4. • Impact Update: CPR willingness grows in the U.S., need to act remains

     Digital Journal· 5 days ago

     [1] 2023 HOCPR Insights survey, American Heart Association [2] 2023 HOCPR Insights survey, American Heart Association [3] Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora ...

5. • 

     Too Much Sun? Here’s How to Tell If You Have Sunburn or Sun Poisoning

     Verywell Health via Yahoo News· 2 days ago

     Sunburn and sun poisoning are both types of skin damage caused by overexposure to the sun’s UV rays....

6. • 

     A human-performance scientist shares the 9 supplements he takes daily for gut, brain, and muscle...

     INSIDER via Yahoo News· 4 days ago

     Professor Andy Galpin, whose clients include the LA Clippers and Travis Barker, adjusts his daily...

7. • 

     These MD Architects Want to Redesign Your Hospital

     Medscape· 3 days ago

     Little known fact: Florence Nightingale might have been the most famous clinician to notice and openly comment on the role of hospital design in patient...

8. • 

     A human-performance scientist shares the 9 supplements he takes daily for gut, brain, and muscle...

     Business Insider· 4 days ago

     This story is available exclusively to Business Insider subscribers. Become an Insider and start...

9. • Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of...

     Tehachapi News· 6 days ago

     Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...

10. • How 7 health systems are spending donations

      Becker’s Hospital Review· 4 days ago

      Mark Keroack, MD, president and CEO of Springfield, Mass.-based Baystate Health, and his wife, Ann Errichetti, MD, have created an endowed fund to support ...